Zota Health Care Limited Sets Upper Cap on Promoter Directors' Cumulative Remuneration
Zota Health Care Limited announced that a group of Promoter Directors has agreed to voluntarily fix an upper cap limit on the cumulative remuneration payable to them. The measure is intended to enhance corporate governance practices, moderate managerial pay, and facilitate the better allocation of capital for the company's overall growth.The agreement involves several key Promoter Directors, including Non-executive Chairman Mr. Ketankumar Chandulal Zota, Whole-time Directors Mr. Himanshu Muktilal Zota, Mr. Kamlesh Rajanikant Zota, Mr. Viren Manukant Zota, and Managing Director Mr. Moxesh Ketanbhai Zota.
Under the agreement, the Promoter Directors have consented to limit the total cumulative remuneration payable to them, encompassing all perquisites and allowances, to a fixed upper cap limit.
The aggregate upper cap limit has been set at Rs. 12.00 crores. This cap is effective and valid until the end of the financial year 2030.
The company stated that this initiative reflects a commitment to better corporate governance and ensuring that managerial compensation is structured to support the sustainable expansion of the business.
ZOTA Stock Price Movement
On Friday, Zota Health Care Limited shares slipped by 2.16% to close at ₹1192.6. The stock experienced a trading range between ₹1185.2 and ₹1223, settling the day on a total volume of 26,128 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.